Zika virus may be useful in treating brain tumours

Conclusion This is an interesting piece of research that shows how knowledge in one field of medicine can sometimes be applied to another field with surprising results. But it's important to be realistic about the stage of research. This is very much a "proof of concept" study, and tests on cells, tissues and mice don't necessarily translate into a safe and effective treatment for humans. The study has several limitations, but the fact the treatment so far hasn't been tested on humans is the most important. For one thing, Zika virus doesn't naturally infect mice, so researchers had to use a specially engineered virus that's different from the virus that infects humans. Also, the glioma tumours in mice were taken from mouse models, so they weren't the same as human glioma tumours. The researchers say there are "technical challenges" to overcome before they can test human-derived glioma cells in mice. They say it may be possible to make the Zika virus safe enough to use in glioma treatment, possibly by injecting it into tumour sites at the same time as surgery to remove tumours. But clinical trials of such a therapy are still some way off. Links To The Headlines Zika virus used to treat aggressive brain cancer. BBC News, September 5 2017 Zika can kill brain tumors like John McCain's, study shows - paving the way to a groundbreaking new use for the mosquito-borne virus. Mail Online, September 5 2017 Links To Science Zhu Z, Gorman MJ, McKenzie LD, et al. Zi...
Source: NHS News Feed - Category: Consumer Health News Tags: Cancer Source Type: news

Related Links:

A new study inCancer Management and Research found a correlation between the age of patients with papillary thyroid cancer and lymph node positivity.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news
Measures of frailty and comorbidity failed to offer predictive information regarding complications in patients with bladder cancer undergoing radical cystectomy.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?, Published online: 17 October 2018; doi:10.1038/s41416-018-0245-0Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Waist circumference and risk of 23 site-specific cancers: a population-based cohort study of Korean adults, Published online: 17 October 2018; doi:10.1038/s41416-018-0214-7Waist circumference and risk of 23 site-specific cancers: a population-based cohort study of Korean adults
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer, Published online: 17 October 2018; doi:10.1038/s41416-018-0296-2Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer, Published online: 17 October 2018; doi:10.1038/s41416-018-0291-7CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Breast osteoblast-like cells: a new biomarker for the management of breast cancer, Published online: 17 October 2018; doi:10.1038/s41416-018-0255-yBreast osteoblast-like cells: a new biomarker for the management of breast cancer
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Combination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma, Published online: 17 October 2018; doi:10.1038/s41416-018-0175-xCombination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers, Published online: 17 October 2018; doi:10.1038/s41416-018-0276-6A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Response to ‘Comment on ‘Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study”Response to ‘Comment on ‘Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study”, Published online: 17 October 2018; doi:10.1038/s41416-018-0177-8Response to ‘Comment on ‘Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study”
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Clinical Trials | Epidemics | Epidemiology | Glioma | Grants | Health | Laboratory Medicine | Neurology | Pregnancy | Science | Stem Cell Therapy | Stem Cells | Study | Temodar | Texas University | Washington University | West Nile Virus | Zika Virus